source name	characteristics[organism]	characteristics[organism part]	characteristics[cell type]	characteristics[ancestry category]	characteristics[age]	characteristics[individual]	characteristics[sex]	characteristics[developmental stage]	characteristics[disease]	characteristics[depletion]	characteristics[depletion method]	characteristics[biological replicate]	assay name	Technology type	comment[data file]	comment[file uri]	comment[fragment weight]	comment[fraction identifier]	comment[fractionation method]	comment[proteomics data acquisition method]	comment[label]	comment[technical replicate]	comment[cleavage agent details]	comment[instrument]	comment[separation]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	comment[dissociation method]	comment[collision energy]	comment[precursor mass tolerance]	comment[fragment mass tolerance]	factor value[organism part]
PXD033169-Sample-1	Homo sapiens	blood serum	not applicable	not applicable	not applicable	77Y-15Y	female	not applicable	benign cancer (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 1	proteomic profiling by mass spectrometry	Benign_25ug_FAIMS_180min_FN01_C1_061821.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Benign_25ug_FAIMS_180min_FN01_C1_061821.raw	25 ug	1	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-2	Homo sapiens	blood serum	not applicable	not applicable	not applicable	77Y-15Y	female	not applicable	benign cancer (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 2	proteomic profiling by mass spectrometry	Benign_25ug_FAIMS_180min_FN02_C2_061821.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Benign_25ug_FAIMS_180min_FN02_C2_061821.raw	25 ug	2	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-3	Homo sapiens	blood serum	not applicable	not applicable	not applicable	77Y-15Y	female	not applicable	benign cancer (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 3	proteomic profiling by mass spectrometry	Benign_25ug_FAIMS_180min_FN03_C1_061821.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Benign_25ug_FAIMS_180min_FN03_C1_061821.raw	25 ug	3	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-4	Homo sapiens	blood serum	not applicable	not applicable	not applicable	77Y-15Y	female	not applicable	benign cancer (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 4	proteomic profiling by mass spectrometry	Benign_25ug_FAIMS_180min_FN04_C2_061821.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Benign_25ug_FAIMS_180min_FN04_C2_061821.raw	25 ug	4	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-5	Homo sapiens	blood serum	not applicable	not applicable	not applicable	77Y-15Y	female	not applicable	benign cancer (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 5	proteomic profiling by mass spectrometry	Benign_25ug_FAIMS_180min_FN05_C1_061821.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Benign_25ug_FAIMS_180min_FN05_C1_061821.raw	25 ug	5	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-6	Homo sapiens	blood serum	not applicable	not applicable	not applicable	77Y-15Y	female	not applicable	benign cancer (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 6	proteomic profiling by mass spectrometry	Benign_25ug_FAIMS_180min_FN06_C2_061821.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Benign_25ug_FAIMS_180min_FN06_C2_061821.raw	25 ug	6	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-7	Homo sapiens	blood serum	not applicable	not applicable	not applicable	77Y-15Y	female	not applicable	benign cancer (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 7	proteomic profiling by mass spectrometry	Benign_25ug_FAIMS_180min_FN07_C1_061821.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Benign_25ug_FAIMS_180min_FN07_C1_061821.raw	25 ug	7	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-8	Homo sapiens	blood serum	not applicable	not applicable	not applicable	77Y-15Y	female	not applicable	benign cancer (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 8	proteomic profiling by mass spectrometry	Benign_25ug_FAIMS_180min_FN08_C2_061821.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Benign_25ug_FAIMS_180min_FN08_C2_061821.raw	25 ug	8	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-9	Homo sapiens	blood serum	not applicable	not applicable	not applicable	77Y-15Y	female	not applicable	benign cancer (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 9	proteomic profiling by mass spectrometry	Benign_25ug_FAIMS_180min_FN09_C1_061821.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Benign_25ug_FAIMS_180min_FN09_C1_061821.raw	25 ug	9	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-10	Homo sapiens	blood serum	not applicable	not applicable	not applicable	77Y-15Y	female	not applicable	benign cancer (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 10	proteomic profiling by mass spectrometry	Benign_25ug_FAIMS_180min_FN10_C2_061821.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Benign_25ug_FAIMS_180min_FN10_C2_061821.raw	25 ug	10	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-11	Homo sapiens	blood serum	not applicable	not applicable	not applicable	77Y-15Y	female	not applicable	benign cancer (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 11	proteomic profiling by mass spectrometry	Benign_25ug_FAIMS_180min_FN11_C1_061821.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Benign_25ug_FAIMS_180min_FN11_C1_061821.raw	25 ug	11	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-12	Homo sapiens	blood serum	not applicable	not applicable	not applicable	77Y-15Y	female	not applicable	benign cancer (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 12	proteomic profiling by mass spectrometry	Benign_25ug_FAIMS_180min_FN12_C2_061821.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Benign_25ug_FAIMS_180min_FN12_C2_061821.raw	25 ug	12	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-13	Homo sapiens	blood serum	not applicable	not applicable	not applicable	77Y-15Y	female	not applicable	benign cancer (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 13	proteomic profiling by mass spectrometry	Benign_25ug_FAIMS_180min_FN13_C1_061821.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Benign_25ug_FAIMS_180min_FN13_C1_061821.raw	25 ug	13	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-14	Homo sapiens	blood serum	not applicable	not applicable	not applicable	77Y-15Y	female	not applicable	benign cancer (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 14	proteomic profiling by mass spectrometry	Benign_25ug_FAIMS_180min_FN14_C2_061821.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Benign_25ug_FAIMS_180min_FN14_C2_061821.raw	25 ug	14	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-15	Homo sapiens	blood serum	not applicable	not applicable	not applicable	77Y-15Y	female	not applicable	benign cancer (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 15	proteomic profiling by mass spectrometry	Benign_25ug_FAIMS_180min_FN15_C1_061821.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Benign_25ug_FAIMS_180min_FN15_C1_061821.raw	25 ug	15	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-16	Homo sapiens	blood serum	not applicable	not applicable	not applicable	77Y-15Y	female	not applicable	benign cancer (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 16	proteomic profiling by mass spectrometry	Benign_25ug_FAIMS_180min_FN16_C2_061821.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Benign_25ug_FAIMS_180min_FN16_C2_061821.raw	25 ug	16	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-17	Homo sapiens	blood serum	not applicable	not applicable	not applicable	77Y-15Y	female	not applicable	benign cancer (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 17	proteomic profiling by mass spectrometry	Benign_25ug_FAIMS_180min_FN17_C1_061821.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Benign_25ug_FAIMS_180min_FN17_C1_061821.raw	25 ug	17	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-18	Homo sapiens	blood serum	not applicable	not applicable	not applicable	77Y-15Y	female	not applicable	benign cancer (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 18	proteomic profiling by mass spectrometry	Benign_25ug_FAIMS_180min_FN18_C2_061821.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Benign_25ug_FAIMS_180min_FN18_C2_061821.raw	25 ug	18	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-19	Homo sapiens	blood serum	not applicable	not applicable	not applicable	77Y-15Y	female	not applicable	benign cancer (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 19	proteomic profiling by mass spectrometry	Benign_25ug_FAIMS_180min_FN19_C1_061821.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Benign_25ug_FAIMS_180min_FN19_C1_061821.raw	25 ug	19	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-20	Homo sapiens	blood serum	not applicable	not applicable	not applicable	77Y-15Y	female	not applicable	benign cancer (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 20	proteomic profiling by mass spectrometry	Benign_25ug_FAIMS_180min_FN20_C2_061821.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Benign_25ug_FAIMS_180min_FN20_C2_061821.raw	25 ug	20	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-21	Homo sapiens	blood serum	not applicable	not applicable	not applicable	77Y-15Y	female	not applicable	benign cancer (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 21	proteomic profiling by mass spectrometry	Benign_25ug_FAIMS_180min_FN21_C1_061821.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Benign_25ug_FAIMS_180min_FN21_C1_061821.raw	25 ug	21	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-22	Homo sapiens	blood serum	not applicable	not applicable	not applicable	77Y-15Y	female	not applicable	benign cancer (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 22	proteomic profiling by mass spectrometry	Benign_25ug_FAIMS_180min_FN22_C2_061821.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Benign_25ug_FAIMS_180min_FN22_C2_061821.raw	25 ug	22	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-23	Homo sapiens	blood serum	not applicable	not applicable	not applicable	77Y-15Y	female	not applicable	benign cancer (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 23	proteomic profiling by mass spectrometry	Benign_25ug_FAIMS_180min_FN23_C1_061821.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Benign_25ug_FAIMS_180min_FN23_C1_061821.raw	25 ug	23	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-24	Homo sapiens	blood serum	not applicable	not applicable	not applicable	77Y-15Y	female	not applicable	benign cancer (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 24	proteomic profiling by mass spectrometry	Benign_25ug_FAIMS_180min_FN24_C2_061821.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Benign_25ug_FAIMS_180min_FN24_C2_061821.raw	25 ug	24	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-25	Homo sapiens	blood serum	not applicable	not applicable	not applicable	38Y-63Y	female	not applicable	clear cell (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 25	proteomic profiling by mass spectrometry	ClearCell_25ug_FAIMS_180min_FN01_C1_062921.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/ClearCell_25ug_FAIMS_180min_FN01_C1_062921.raw	25 ug	1	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-26	Homo sapiens	blood serum	not applicable	not applicable	not applicable	38Y-63Y	female	not applicable	clear cell (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 26	proteomic profiling by mass spectrometry	ClearCell_25ug_FAIMS_180min_FN02_C2_062921.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/ClearCell_25ug_FAIMS_180min_FN02_C2_062921.raw	25 ug	2	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-27	Homo sapiens	blood serum	not applicable	not applicable	not applicable	38Y-63Y	female	not applicable	clear cell (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 27	proteomic profiling by mass spectrometry	ClearCell_25ug_FAIMS_180min_FN03_C1_062921.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/ClearCell_25ug_FAIMS_180min_FN03_C1_062921.raw	25 ug	3	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-28	Homo sapiens	blood serum	not applicable	not applicable	not applicable	38Y-63Y	female	not applicable	clear cell (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 28	proteomic profiling by mass spectrometry	ClearCell_25ug_FAIMS_180min_FN04_C2_062921.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/ClearCell_25ug_FAIMS_180min_FN04_C2_062921.raw	25 ug	4	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-29	Homo sapiens	blood serum	not applicable	not applicable	not applicable	38Y-63Y	female	not applicable	clear cell (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 29	proteomic profiling by mass spectrometry	ClearCell_25ug_FAIMS_180min_FN05_C1_062921.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/ClearCell_25ug_FAIMS_180min_FN05_C1_062921.raw	25 ug	5	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-30	Homo sapiens	blood serum	not applicable	not applicable	not applicable	38Y-63Y	female	not applicable	clear cell (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 30	proteomic profiling by mass spectrometry	ClearCell_25ug_FAIMS_180min_FN06_C2_062921.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/ClearCell_25ug_FAIMS_180min_FN06_C2_062921.raw	25 ug	6	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-31	Homo sapiens	blood serum	not applicable	not applicable	not applicable	38Y-63Y	female	not applicable	clear cell (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 31	proteomic profiling by mass spectrometry	ClearCell_25ug_FAIMS_180min_FN07_C1_062921.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/ClearCell_25ug_FAIMS_180min_FN07_C1_062921.raw	25 ug	7	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-32	Homo sapiens	blood serum	not applicable	not applicable	not applicable	38Y-63Y	female	not applicable	clear cell (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 32	proteomic profiling by mass spectrometry	ClearCell_25ug_FAIMS_180min_FN08_C2_062921.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/ClearCell_25ug_FAIMS_180min_FN08_C2_062921.raw	25 ug	8	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-33	Homo sapiens	blood serum	not applicable	not applicable	not applicable	38Y-63Y	female	not applicable	clear cell (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 33	proteomic profiling by mass spectrometry	ClearCell_25ug_FAIMS_180min_FN09_C1_062921.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/ClearCell_25ug_FAIMS_180min_FN09_C1_062921.raw	25 ug	9	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-34	Homo sapiens	blood serum	not applicable	not applicable	not applicable	38Y-63Y	female	not applicable	clear cell (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 34	proteomic profiling by mass spectrometry	ClearCell_25ug_FAIMS_180min_FN10_C2_062921.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/ClearCell_25ug_FAIMS_180min_FN10_C2_062921.raw	25 ug	10	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-35	Homo sapiens	blood serum	not applicable	not applicable	not applicable	38Y-63Y	female	not applicable	clear cell (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 35	proteomic profiling by mass spectrometry	ClearCell_25ug_FAIMS_180min_FN11_C1_062921.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/ClearCell_25ug_FAIMS_180min_FN11_C1_062921.raw	25 ug	11	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-36	Homo sapiens	blood serum	not applicable	not applicable	not applicable	38Y-63Y	female	not applicable	clear cell (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 36	proteomic profiling by mass spectrometry	ClearCell_25ug_FAIMS_180min_FN12_C2_062921.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/ClearCell_25ug_FAIMS_180min_FN12_C2_062921.raw	25 ug	12	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-37	Homo sapiens	blood serum	not applicable	not applicable	not applicable	38Y-63Y	female	not applicable	clear cell (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 37	proteomic profiling by mass spectrometry	ClearCell_25ug_FAIMS_180min_FN13_C1_062921.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/ClearCell_25ug_FAIMS_180min_FN13_C1_062921.raw	25 ug	13	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-38	Homo sapiens	blood serum	not applicable	not applicable	not applicable	38Y-63Y	female	not applicable	clear cell (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 38	proteomic profiling by mass spectrometry	ClearCell_25ug_FAIMS_180min_FN14_C2_062921.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/ClearCell_25ug_FAIMS_180min_FN14_C2_062921.raw	25 ug	14	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-39	Homo sapiens	blood serum	not applicable	not applicable	not applicable	38Y-63Y	female	not applicable	clear cell (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 39	proteomic profiling by mass spectrometry	ClearCell_25ug_FAIMS_180min_FN15_C1_062921.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/ClearCell_25ug_FAIMS_180min_FN15_C1_062921.raw	25 ug	15	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-40	Homo sapiens	blood serum	not applicable	not applicable	not applicable	38Y-63Y	female	not applicable	clear cell (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 40	proteomic profiling by mass spectrometry	ClearCell_25ug_FAIMS_180min_FN16_C2_062921.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/ClearCell_25ug_FAIMS_180min_FN16_C2_062921.raw	25 ug	16	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-41	Homo sapiens	blood serum	not applicable	not applicable	not applicable	38Y-63Y	female	not applicable	clear cell (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 41	proteomic profiling by mass spectrometry	ClearCell_25ug_FAIMS_180min_FN17_C1_062921.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/ClearCell_25ug_FAIMS_180min_FN17_C1_062921.raw	25 ug	17	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-42	Homo sapiens	blood serum	not applicable	not applicable	not applicable	38Y-63Y	female	not applicable	clear cell (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 42	proteomic profiling by mass spectrometry	ClearCell_25ug_FAIMS_180min_FN18_C2_062921.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/ClearCell_25ug_FAIMS_180min_FN18_C2_062921.raw	25 ug	18	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-43	Homo sapiens	blood serum	not applicable	not applicable	not applicable	38Y-63Y	female	not applicable	clear cell (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 43	proteomic profiling by mass spectrometry	ClearCell_25ug_FAIMS_180min_FN19_C1_062921.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/ClearCell_25ug_FAIMS_180min_FN19_C1_062921.raw	25 ug	19	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-44	Homo sapiens	blood serum	not applicable	not applicable	not applicable	38Y-63Y	female	not applicable	clear cell (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 44	proteomic profiling by mass spectrometry	ClearCell_25ug_FAIMS_180min_FN20_C2_062921.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/ClearCell_25ug_FAIMS_180min_FN20_C2_062921.raw	25 ug	20	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-45	Homo sapiens	blood serum	not applicable	not applicable	not applicable	38Y-63Y	female	not applicable	clear cell (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 45	proteomic profiling by mass spectrometry	ClearCell_25ug_FAIMS_180min_FN21_C1_062921.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/ClearCell_25ug_FAIMS_180min_FN21_C1_062921.raw	25 ug	21	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-46	Homo sapiens	blood serum	not applicable	not applicable	not applicable	38Y-63Y	female	not applicable	clear cell (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 46	proteomic profiling by mass spectrometry	ClearCell_25ug_FAIMS_180min_FN22_C2_062921.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/ClearCell_25ug_FAIMS_180min_FN22_C2_062921.raw	25 ug	22	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-47	Homo sapiens	blood serum	not applicable	not applicable	not applicable	38Y-63Y	female	not applicable	clear cell (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 47	proteomic profiling by mass spectrometry	ClearCell_25ug_FAIMS_180min_FN23_C1_062921.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/ClearCell_25ug_FAIMS_180min_FN23_C1_062921.raw	25 ug	23	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-48	Homo sapiens	blood serum	not applicable	not applicable	not applicable	38Y-63Y	female	not applicable	clear cell (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 48	proteomic profiling by mass spectrometry	ClearCell_25ug_FAIMS_180min_FN24_C2_062921.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/ClearCell_25ug_FAIMS_180min_FN24_C2_062921.raw	25 ug	24	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-49	Homo sapiens	blood serum	not applicable	not applicable	not applicable	38Y-63Y	female	not applicable	clear cell (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 49	proteomic profiling by mass spectrometry	ClearCell_50ug_FAIMS_180min_FN01_C1_071521.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/ClearCell_50ug_FAIMS_180min_FN01_C1_071521.raw	25 ug	1	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-50	Homo sapiens	blood serum	not applicable	not applicable	not applicable	38Y-63Y	female	not applicable	clear cell (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 50	proteomic profiling by mass spectrometry	ClearCell_50ug_FAIMS_180min_FN02_C2_071521.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/ClearCell_50ug_FAIMS_180min_FN02_C2_071521.raw	25 ug	2	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-51	Homo sapiens	blood serum	not applicable	not applicable	not applicable	38Y-63Y	female	not applicable	clear cell (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 51	proteomic profiling by mass spectrometry	ClearCell_50ug_FAIMS_180min_FN03_C1_071521.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/ClearCell_50ug_FAIMS_180min_FN03_C1_071521.raw	50 ug	3	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-52	Homo sapiens	blood serum	not applicable	not applicable	not applicable	38Y-63Y	female	not applicable	clear cell (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 52	proteomic profiling by mass spectrometry	ClearCell_50ug_FAIMS_180min_FN04_C2_071521.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/ClearCell_50ug_FAIMS_180min_FN04_C2_071521.raw	50 ug	4	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-53	Homo sapiens	blood serum	not applicable	not applicable	not applicable	38Y-63Y	female	not applicable	clear cell (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 53	proteomic profiling by mass spectrometry	ClearCell_50ug_FAIMS_180min_FN05_C1_071521.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/ClearCell_50ug_FAIMS_180min_FN05_C1_071521.raw	50 ug	5	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-54	Homo sapiens	blood serum	not applicable	not applicable	not applicable	38Y-63Y	female	not applicable	clear cell (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 54	proteomic profiling by mass spectrometry	ClearCell_50ug_FAIMS_180min_FN06_C2_071521.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/ClearCell_50ug_FAIMS_180min_FN06_C2_071521.raw	50 ug	6	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-55	Homo sapiens	blood serum	not applicable	not applicable	not applicable	38Y-63Y	female	not applicable	clear cell (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 55	proteomic profiling by mass spectrometry	ClearCell_50ug_FAIMS_180min_FN07_C1_071521.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/ClearCell_50ug_FAIMS_180min_FN07_C1_071521.raw	50 ug	7	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-56	Homo sapiens	blood serum	not applicable	not applicable	not applicable	38Y-63Y	female	not applicable	clear cell (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 56	proteomic profiling by mass spectrometry	ClearCell_50ug_FAIMS_180min_FN08_C2_071521.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/ClearCell_50ug_FAIMS_180min_FN08_C2_071521.raw	50 ug	8	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-57	Homo sapiens	blood serum	not applicable	not applicable	not applicable	38Y-63Y	female	not applicable	clear cell (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 57	proteomic profiling by mass spectrometry	ClearCell_50ug_FAIMS_180min_FN09_C1_071521.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/ClearCell_50ug_FAIMS_180min_FN09_C1_071521.raw	50 ug	9	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-58	Homo sapiens	blood serum	not applicable	not applicable	not applicable	38Y-63Y	female	not applicable	clear cell (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 58	proteomic profiling by mass spectrometry	ClearCell_50ug_FAIMS_180min_FN10_C2_071521.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/ClearCell_50ug_FAIMS_180min_FN10_C2_071521.raw	50 ug	10	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-59	Homo sapiens	blood serum	not applicable	not applicable	not applicable	38Y-63Y	female	not applicable	clear cell (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 59	proteomic profiling by mass spectrometry	ClearCell_50ug_FAIMS_180min_FN11_C1_071521.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/ClearCell_50ug_FAIMS_180min_FN11_C1_071521.raw	50 ug	11	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-60	Homo sapiens	blood serum	not applicable	not applicable	not applicable	38Y-63Y	female	not applicable	clear cell (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 60	proteomic profiling by mass spectrometry	ClearCell_50ug_FAIMS_180min_FN12_C2_071521.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/ClearCell_50ug_FAIMS_180min_FN12_C2_071521.raw	50 ug	12	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-61	Homo sapiens	blood serum	not applicable	not applicable	not applicable	38Y-63Y	female	not applicable	clear cell (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 61	proteomic profiling by mass spectrometry	ClearCell_50ug_FAIMS_180min_FN13_C1_071521.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/ClearCell_50ug_FAIMS_180min_FN13_C1_071521.raw	50 ug	13	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-62	Homo sapiens	blood serum	not applicable	not applicable	not applicable	38Y-63Y	female	not applicable	clear cell (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 62	proteomic profiling by mass spectrometry	ClearCell_50ug_FAIMS_180min_FN14_C2_071521.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/ClearCell_50ug_FAIMS_180min_FN14_C2_071521.raw	50 ug	14	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-63	Homo sapiens	blood serum	not applicable	not applicable	not applicable	38Y-63Y	female	not applicable	clear cell (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 63	proteomic profiling by mass spectrometry	ClearCell_50ug_FAIMS_180min_FN15_C1_071521.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/ClearCell_50ug_FAIMS_180min_FN15_C1_071521.raw	50 ug	15	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-64	Homo sapiens	blood serum	not applicable	not applicable	not applicable	38Y-63Y	female	not applicable	clear cell (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 64	proteomic profiling by mass spectrometry	ClearCell_50ug_FAIMS_180min_FN16_C2_071521.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/ClearCell_50ug_FAIMS_180min_FN16_C2_071521.raw	50 ug	16	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-65	Homo sapiens	blood serum	not applicable	not applicable	not applicable	38Y-63Y	female	not applicable	clear cell (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 65	proteomic profiling by mass spectrometry	ClearCell_50ug_FAIMS_180min_FN17_C1_071521.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/ClearCell_50ug_FAIMS_180min_FN17_C1_071521.raw	50 ug	17	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-66	Homo sapiens	blood serum	not applicable	not applicable	not applicable	38Y-63Y	female	not applicable	clear cell (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 66	proteomic profiling by mass spectrometry	ClearCell_50ug_FAIMS_180min_FN18_C2_071521.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/ClearCell_50ug_FAIMS_180min_FN18_C2_071521.raw	50 ug	18	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-67	Homo sapiens	blood serum	not applicable	not applicable	not applicable	38Y-63Y	female	not applicable	clear cell (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 67	proteomic profiling by mass spectrometry	ClearCell_50ug_FAIMS_180min_FN19_C1_071521.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/ClearCell_50ug_FAIMS_180min_FN19_C1_071521.raw	50 ug	19	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-68	Homo sapiens	blood serum	not applicable	not applicable	not applicable	38Y-63Y	female	not applicable	clear cell (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 68	proteomic profiling by mass spectrometry	ClearCell_50ug_FAIMS_180min_FN20_C2_071521.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/ClearCell_50ug_FAIMS_180min_FN20_C2_071521.raw	50 ug	20	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-69	Homo sapiens	blood serum	not applicable	not applicable	not applicable	38Y-63Y	female	not applicable	clear cell (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 69	proteomic profiling by mass spectrometry	ClearCell_50ug_FAIMS_180min_FN21_C1_071521.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/ClearCell_50ug_FAIMS_180min_FN21_C1_071521.raw	50 ug	21	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-70	Homo sapiens	blood serum	not applicable	not applicable	not applicable	38Y-63Y	female	not applicable	clear cell (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 70	proteomic profiling by mass spectrometry	ClearCell_50ug_FAIMS_180min_FN22_C2_071521.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/ClearCell_50ug_FAIMS_180min_FN22_C2_071521.raw	50 ug	22	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-71	Homo sapiens	blood serum	not applicable	not applicable	not applicable	38Y-63Y	female	not applicable	clear cell (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 71	proteomic profiling by mass spectrometry	ClearCell_50ug_FAIMS_180min_FN23_C1_071521.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/ClearCell_50ug_FAIMS_180min_FN23_C1_071521.raw	50 ug	23	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-72	Homo sapiens	blood serum	not applicable	not applicable	not applicable	38Y-63Y	female	not applicable	clear cell (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 72	proteomic profiling by mass spectrometry	ClearCell_50ug_FAIMS_180min_FN24_C2_071521.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/ClearCell_50ug_FAIMS_180min_FN24_C2_071521.raw	50 ug	24	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-73	Homo sapiens	blood serum	not applicable	not applicable	not applicable	41Y-62Y	female	not applicable	endometroid (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 73	proteomic profiling by mass spectrometry	Endomet_25ug_FAIMS_180min_FN01_C1_062221.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Endomet_25ug_FAIMS_180min_FN01_C1_062221.raw	25 ug	1	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-74	Homo sapiens	blood serum	not applicable	not applicable	not applicable	41Y-62Y	female	not applicable	endometroid (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 74	proteomic profiling by mass spectrometry	Endomet_25ug_FAIMS_180min_FN02_C2_062221.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Endomet_25ug_FAIMS_180min_FN02_C2_062221.raw	25 ug	2	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-75	Homo sapiens	blood serum	not applicable	not applicable	not applicable	41Y-62Y	female	not applicable	endometroid (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 75	proteomic profiling by mass spectrometry	Endomet_25ug_FAIMS_180min_FN03_C1_062221.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Endomet_25ug_FAIMS_180min_FN03_C1_062221.raw	25 ug	3	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-76	Homo sapiens	blood serum	not applicable	not applicable	not applicable	41Y-62Y	female	not applicable	endometroid (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 76	proteomic profiling by mass spectrometry	Endomet_25ug_FAIMS_180min_FN04_C2_062221.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Endomet_25ug_FAIMS_180min_FN04_C2_062221.raw	25 ug	4	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-77	Homo sapiens	blood serum	not applicable	not applicable	not applicable	41Y-62Y	female	not applicable	endometroid (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 77	proteomic profiling by mass spectrometry	Endomet_25ug_FAIMS_180min_FN05_C1_062221.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Endomet_25ug_FAIMS_180min_FN05_C1_062221.raw	25 ug	5	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-78	Homo sapiens	blood serum	not applicable	not applicable	not applicable	41Y-62Y	female	not applicable	endometroid (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 78	proteomic profiling by mass spectrometry	Endomet_25ug_FAIMS_180min_FN06_C2_062221.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Endomet_25ug_FAIMS_180min_FN06_C2_062221.raw	25 ug	6	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-79	Homo sapiens	blood serum	not applicable	not applicable	not applicable	41Y-62Y	female	not applicable	endometroid (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 79	proteomic profiling by mass spectrometry	Endomet_25ug_FAIMS_180min_FN08_C2_062221.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Endomet_25ug_FAIMS_180min_FN08_C2_062221.raw	25 ug	7	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-80	Homo sapiens	blood serum	not applicable	not applicable	not applicable	41Y-62Y	female	not applicable	endometroid (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 80	proteomic profiling by mass spectrometry	Endomet_25ug_FAIMS_180min_FN09_C1_062221.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Endomet_25ug_FAIMS_180min_FN09_C1_062221.raw	25 ug	8	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-81	Homo sapiens	blood serum	not applicable	not applicable	not applicable	41Y-62Y	female	not applicable	endometroid (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 81	proteomic profiling by mass spectrometry	Endomet_25ug_FAIMS_180min_FN10_C2_062221.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Endomet_25ug_FAIMS_180min_FN10_C2_062221.raw	25 ug	9	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-82	Homo sapiens	blood serum	not applicable	not applicable	not applicable	41Y-62Y	female	not applicable	endometroid (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 82	proteomic profiling by mass spectrometry	Endomet_25ug_FAIMS_180min_FN11_C1_062221.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Endomet_25ug_FAIMS_180min_FN11_C1_062221.raw	25 ug	10	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-83	Homo sapiens	blood serum	not applicable	not applicable	not applicable	41Y-62Y	female	not applicable	endometroid (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 83	proteomic profiling by mass spectrometry	Endomet_25ug_FAIMS_180min_FN12_C2_062221.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Endomet_25ug_FAIMS_180min_FN12_C2_062221.raw	25 ug	11	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-84	Homo sapiens	blood serum	not applicable	not applicable	not applicable	41Y-62Y	female	not applicable	endometroid (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 84	proteomic profiling by mass spectrometry	Endomet_25ug_FAIMS_180min_FN13_C1_062221.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Endomet_25ug_FAIMS_180min_FN13_C1_062221.raw	25 ug	12	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-85	Homo sapiens	blood serum	not applicable	not applicable	not applicable	41Y-62Y	female	not applicable	endometroid (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 85	proteomic profiling by mass spectrometry	Endomet_25ug_FAIMS_180min_FN14_C2_062221.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Endomet_25ug_FAIMS_180min_FN14_C2_062221.raw	25 ug	13	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-86	Homo sapiens	blood serum	not applicable	not applicable	not applicable	41Y-62Y	female	not applicable	endometroid (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 86	proteomic profiling by mass spectrometry	Endomet_25ug_FAIMS_180min_FN15_C1_062221.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Endomet_25ug_FAIMS_180min_FN15_C1_062221.raw	25 ug	14	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-87	Homo sapiens	blood serum	not applicable	not applicable	not applicable	41Y-62Y	female	not applicable	endometroid (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 87	proteomic profiling by mass spectrometry	Endomet_25ug_FAIMS_180min_FN16_C2_062221.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Endomet_25ug_FAIMS_180min_FN16_C2_062221.raw	25 ug	15	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-88	Homo sapiens	blood serum	not applicable	not applicable	not applicable	41Y-62Y	female	not applicable	endometroid (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 88	proteomic profiling by mass spectrometry	Endomet_25ug_FAIMS_180min_FN17_C1_062221.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Endomet_25ug_FAIMS_180min_FN17_C1_062221.raw	25 ug	16	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-89	Homo sapiens	blood serum	not applicable	not applicable	not applicable	41Y-62Y	female	not applicable	endometroid (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 89	proteomic profiling by mass spectrometry	Endomet_25ug_FAIMS_180min_FN18_C2_062221.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Endomet_25ug_FAIMS_180min_FN18_C2_062221.raw	25 ug	17	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-90	Homo sapiens	blood serum	not applicable	not applicable	not applicable	41Y-62Y	female	not applicable	endometroid (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 90	proteomic profiling by mass spectrometry	Endomet_25ug_FAIMS_180min_FN19_C1_062221.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Endomet_25ug_FAIMS_180min_FN19_C1_062221.raw	25 ug	18	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-91	Homo sapiens	blood serum	not applicable	not applicable	not applicable	41Y-62Y	female	not applicable	endometroid (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 91	proteomic profiling by mass spectrometry	Endomet_25ug_FAIMS_180min_FN20_C2_062221.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Endomet_25ug_FAIMS_180min_FN20_C2_062221.raw	25 ug	19	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-92	Homo sapiens	blood serum	not applicable	not applicable	not applicable	41Y-62Y	female	not applicable	endometroid (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 92	proteomic profiling by mass spectrometry	Endomet_25ug_FAIMS_180min_FN21_C1_062221.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Endomet_25ug_FAIMS_180min_FN21_C1_062221.raw	25 ug	20	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-93	Homo sapiens	blood serum	not applicable	not applicable	not applicable	41Y-62Y	female	not applicable	endometroid (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 93	proteomic profiling by mass spectrometry	Endomet_25ug_FAIMS_180min_FN22_C2_062221.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Endomet_25ug_FAIMS_180min_FN22_C2_062221.raw	25 ug	21	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-94	Homo sapiens	blood serum	not applicable	not applicable	not applicable	41Y-62Y	female	not applicable	endometroid (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 94	proteomic profiling by mass spectrometry	Endomet_25ug_FAIMS_180min_FN23_C1_062221.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Endomet_25ug_FAIMS_180min_FN23_C1_062221.raw	25 ug	22	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-95	Homo sapiens	blood serum	not applicable	not applicable	not applicable	41Y-62Y	female	not applicable	endometroid (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 95	proteomic profiling by mass spectrometry	Endomet_25ug_FAIMS_180min_FN24_C2_062221.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Endomet_25ug_FAIMS_180min_FN24_C2_062221.raw	25 ug	23	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-96	Homo sapiens	blood serum	not applicable	not applicable	not applicable	41Y-62Y	female	not applicable	endometroid (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 96	proteomic profiling by mass spectrometry	Endomet_50ug_FAIMS_180min_FN01_C1_071021.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Endomet_50ug_FAIMS_180min_FN01_C1_071021.raw	50 ug	1	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-97	Homo sapiens	blood serum	not applicable	not applicable	not applicable	41Y-62Y	female	not applicable	endometroid (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 97	proteomic profiling by mass spectrometry	Endomet_50ug_FAIMS_180min_FN02_C2_071021.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Endomet_50ug_FAIMS_180min_FN02_C2_071021.raw	50 ug	2	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-98	Homo sapiens	blood serum	not applicable	not applicable	not applicable	41Y-62Y	female	not applicable	endometroid (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 98	proteomic profiling by mass spectrometry	Endomet_50ug_FAIMS_180min_FN03_C1_071021.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Endomet_50ug_FAIMS_180min_FN03_C1_071021.raw	50 ug	3	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-99	Homo sapiens	blood serum	not applicable	not applicable	not applicable	41Y-62Y	female	not applicable	endometroid (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 99	proteomic profiling by mass spectrometry	Endomet_50ug_FAIMS_180min_FN04_C2_071021.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Endomet_50ug_FAIMS_180min_FN04_C2_071021.raw	50 ug	4	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-100	Homo sapiens	blood serum	not applicable	not applicable	not applicable	41Y-62Y	female	not applicable	endometroid (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 100	proteomic profiling by mass spectrometry	Endomet_50ug_FAIMS_180min_FN05_C1_071021.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Endomet_50ug_FAIMS_180min_FN05_C1_071021.raw	50 ug	5	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-101	Homo sapiens	blood serum	not applicable	not applicable	not applicable	41Y-62Y	female	not applicable	endometroid (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 101	proteomic profiling by mass spectrometry	Endomet_50ug_FAIMS_180min_FN06_C2_071021.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Endomet_50ug_FAIMS_180min_FN06_C2_071021.raw	50 ug	6	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-102	Homo sapiens	blood serum	not applicable	not applicable	not applicable	41Y-62Y	female	not applicable	endometroid (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 102	proteomic profiling by mass spectrometry	Endomet_50ug_FAIMS_180min_FN07_C1_071021.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Endomet_50ug_FAIMS_180min_FN07_C1_071021.raw	50 ug	7	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-103	Homo sapiens	blood serum	not applicable	not applicable	not applicable	41Y-62Y	female	not applicable	endometroid (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 103	proteomic profiling by mass spectrometry	Endomet_50ug_FAIMS_180min_FN08_C2_071021.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Endomet_50ug_FAIMS_180min_FN08_C2_071021.raw	50 ug	8	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-104	Homo sapiens	blood serum	not applicable	not applicable	not applicable	41Y-62Y	female	not applicable	endometroid (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 104	proteomic profiling by mass spectrometry	Endomet_50ug_FAIMS_180min_FN09_C1_071021.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Endomet_50ug_FAIMS_180min_FN09_C1_071021.raw	50 ug	9	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-105	Homo sapiens	blood serum	not applicable	not applicable	not applicable	41Y-62Y	female	not applicable	endometroid (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 105	proteomic profiling by mass spectrometry	Endomet_50ug_FAIMS_180min_FN10_C2_071021.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Endomet_50ug_FAIMS_180min_FN10_C2_071021.raw	50 ug	10	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-106	Homo sapiens	blood serum	not applicable	not applicable	not applicable	41Y-62Y	female	not applicable	endometroid (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 106	proteomic profiling by mass spectrometry	Endomet_50ug_FAIMS_180min_FN11_C1_071021.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Endomet_50ug_FAIMS_180min_FN11_C1_071021.raw	50 ug	11	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-107	Homo sapiens	blood serum	not applicable	not applicable	not applicable	41Y-62Y	female	not applicable	endometroid (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 107	proteomic profiling by mass spectrometry	Endomet_50ug_FAIMS_180min_FN12_C2_071021.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Endomet_50ug_FAIMS_180min_FN12_C2_071021.raw	50 ug	12	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-108	Homo sapiens	blood serum	not applicable	not applicable	not applicable	41Y-62Y	female	not applicable	endometroid (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 108	proteomic profiling by mass spectrometry	Endomet_50ug_FAIMS_180min_FN13_C1_071021.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Endomet_50ug_FAIMS_180min_FN13_C1_071021.raw	50 ug	13	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-109	Homo sapiens	blood serum	not applicable	not applicable	not applicable	41Y-62Y	female	not applicable	endometroid (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 109	proteomic profiling by mass spectrometry	Endomet_50ug_FAIMS_180min_FN14_C2_071021.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Endomet_50ug_FAIMS_180min_FN14_C2_071021.raw	50 ug	14	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-110	Homo sapiens	blood serum	not applicable	not applicable	not applicable	41Y-62Y	female	not applicable	endometroid (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 110	proteomic profiling by mass spectrometry	Endomet_50ug_FAIMS_180min_FN15_C1_071021.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Endomet_50ug_FAIMS_180min_FN15_C1_071021.raw	50 ug	15	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-111	Homo sapiens	blood serum	not applicable	not applicable	not applicable	41Y-62Y	female	not applicable	endometroid (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 111	proteomic profiling by mass spectrometry	Endomet_50ug_FAIMS_180min_FN16_C2_071021.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Endomet_50ug_FAIMS_180min_FN16_C2_071021.raw	50 ug	16	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-112	Homo sapiens	blood serum	not applicable	not applicable	not applicable	41Y-62Y	female	not applicable	endometroid (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 112	proteomic profiling by mass spectrometry	Endomet_50ug_FAIMS_180min_FN17_C1_071021.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Endomet_50ug_FAIMS_180min_FN17_C1_071021.raw	50 ug	17	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-113	Homo sapiens	blood serum	not applicable	not applicable	not applicable	41Y-62Y	female	not applicable	endometroid (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 113	proteomic profiling by mass spectrometry	Endomet_50ug_FAIMS_180min_FN18_C2_071021.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Endomet_50ug_FAIMS_180min_FN18_C2_071021.raw	50 ug	18	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-114	Homo sapiens	blood serum	not applicable	not applicable	not applicable	41Y-62Y	female	not applicable	endometroid (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 114	proteomic profiling by mass spectrometry	Endomet_50ug_FAIMS_180min_FN19_C1_071021.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Endomet_50ug_FAIMS_180min_FN19_C1_071021.raw	50 ug	19	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-115	Homo sapiens	blood serum	not applicable	not applicable	not applicable	41Y-62Y	female	not applicable	endometroid (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 115	proteomic profiling by mass spectrometry	Endomet_50ug_FAIMS_180min_FN20_C2_071021.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Endomet_50ug_FAIMS_180min_FN20_C2_071021.raw	50 ug	20	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-116	Homo sapiens	blood serum	not applicable	not applicable	not applicable	41Y-62Y	female	not applicable	endometroid (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 116	proteomic profiling by mass spectrometry	Endomet_50ug_FAIMS_180min_FN21_C1_071021.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Endomet_50ug_FAIMS_180min_FN21_C1_071021.raw	50 ug	21	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-117	Homo sapiens	blood serum	not applicable	not applicable	not applicable	41Y-62Y	female	not applicable	endometroid (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 117	proteomic profiling by mass spectrometry	Endomet_50ug_FAIMS_180min_FN22_C2_071021.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Endomet_50ug_FAIMS_180min_FN22_C2_071021.raw	50 ug	22	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-118	Homo sapiens	blood serum	not applicable	not applicable	not applicable	41Y-62Y	female	not applicable	endometroid (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 118	proteomic profiling by mass spectrometry	Endomet_50ug_FAIMS_180min_FN23_C1_071021.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Endomet_50ug_FAIMS_180min_FN23_C1_071021.raw	50 ug	23	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-119	Homo sapiens	blood serum	not applicable	not applicable	not applicable	41Y-62Y	female	not applicable	endometroid (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 119	proteomic profiling by mass spectrometry	Endomet_50ug_FAIMS_180min_FN24_C2_071021.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Endomet_50ug_FAIMS_180min_FN24_C2_071021.raw	50 ug	24	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-120	Homo sapiens	blood serum	not applicable	not applicable	not applicable	33Y-78Y	female	not applicable	high-grade serous ovarian cancer	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 120	proteomic profiling by mass spectrometry	210329_OC_SA01_2ug_iRT3ul.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/210329_OC_SA01_2ug_iRT3ul.raw	2 ug	1	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-121	Homo sapiens	blood serum	not applicable	not applicable	not applicable	33Y-78Y	female	not applicable	high-grade serous ovarian cancer	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 121	proteomic profiling by mass spectrometry	210329_OC_SA02_2ug_iRT3ul.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/210329_OC_SA02_2ug_iRT3ul.raw	2 ug	2	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-122	Homo sapiens	blood serum	not applicable	not applicable	not applicable	33Y-78Y	female	not applicable	high-grade serous ovarian cancer	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 122	proteomic profiling by mass spectrometry	210329_OC_SA04_2ug_iRT3ul.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/210329_OC_SA04_2ug_iRT3ul.raw	2 ug	3	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-123	Homo sapiens	blood serum	not applicable	not applicable	not applicable	33Y-78Y	female	not applicable	high-grade serous ovarian cancer	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 123	proteomic profiling by mass spectrometry	210329_OC_SA05_2ug_iRT3ul.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/210329_OC_SA05_2ug_iRT3ul.raw	2 ug	4	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-124	Homo sapiens	blood serum	not applicable	not applicable	not applicable	33Y-78Y	female	not applicable	high-grade serous ovarian cancer	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 124	proteomic profiling by mass spectrometry	210329_OC_SA06_2ug_iRT3ul.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/210329_OC_SA06_2ug_iRT3ul.raw	2 ug	5	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-125	Homo sapiens	blood serum	not applicable	not applicable	not applicable	33Y-78Y	female	not applicable	high-grade serous ovarian cancer	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 125	proteomic profiling by mass spectrometry	210329_OC_SA09_2ug_iRT3ul.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/210329_OC_SA09_2ug_iRT3ul.raw	2 ug	6	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-126	Homo sapiens	blood serum	not applicable	not applicable	not applicable	33Y-78Y	female	not applicable	high-grade serous ovarian cancer	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 126	proteomic profiling by mass spectrometry	210329_OC_SA10_2ug_iRT3ul.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/210329_OC_SA10_2ug_iRT3ul.raw	2 ug	7	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-127	Homo sapiens	blood serum	not applicable	not applicable	not applicable	33Y-78Y	female	not applicable	high-grade serous ovarian cancer	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 127	proteomic profiling by mass spectrometry	210329_OC_SA11_2ug_iRT3ul.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/210329_OC_SA11_2ug_iRT3ul.raw	2 ug	8	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-128	Homo sapiens	blood serum	not applicable	not applicable	not applicable	33Y-78Y	female	not applicable	high-grade serous ovarian cancer	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 128	proteomic profiling by mass spectrometry	210329_OC_SA15_2ug_iRT3ul.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/210329_OC_SA15_2ug_iRT3ul.raw	2 ug	9	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-129	Homo sapiens	blood serum	not applicable	not applicable	not applicable	33Y-78Y	female	not applicable	high-grade serous ovarian cancer	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 129	proteomic profiling by mass spectrometry	210329_OC_SA16_2ug_iRT3ul.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/210329_OC_SA16_2ug_iRT3ul.raw	2 ug	10	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-130	Homo sapiens	blood serum	not applicable	not applicable	not applicable	33Y-78Y	female	not applicable	high-grade serous ovarian cancer	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 130	proteomic profiling by mass spectrometry	210329_OC_SC01_2ug_iRT3ul.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/210329_OC_SC01_2ug_iRT3ul.raw	2 ug	11	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-131	Homo sapiens	blood serum	not applicable	not applicable	not applicable	33Y-78Y	female	not applicable	high-grade serous ovarian cancer	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 131	proteomic profiling by mass spectrometry	210329_OC_SC02_2ug_iRT3ul.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/210329_OC_SC02_2ug_iRT3ul.raw	2 ug	12	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-132	Homo sapiens	blood serum	not applicable	not applicable	not applicable	33Y-78Y	female	not applicable	high-grade serous ovarian cancer	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 132	proteomic profiling by mass spectrometry	210329_OC_SC04_2ug_iRT3ul.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/210329_OC_SC04_2ug_iRT3ul.raw	2 ug	13	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-133	Homo sapiens	blood serum	not applicable	not applicable	not applicable	33Y-78Y	female	not applicable	high-grade serous ovarian cancer	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 133	proteomic profiling by mass spectrometry	210329_OC_SC06_2ug_iRT3ul.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/210329_OC_SC06_2ug_iRT3ul.raw	2 ug	14	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-134	Homo sapiens	blood serum	not applicable	not applicable	not applicable	33Y-78Y	female	not applicable	high-grade serous ovarian cancer	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 134	proteomic profiling by mass spectrometry	210329_OC_SC08_2ug_iRT3ul.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/210329_OC_SC08_2ug_iRT3ul.raw	2 ug	15	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-135	Homo sapiens	blood serum	not applicable	not applicable	not applicable	33Y-78Y	female	not applicable	high-grade serous ovarian cancer	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 135	proteomic profiling by mass spectrometry	210329_OC_SC10_2ug_iRT3ul.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/210329_OC_SC10_2ug_iRT3ul.raw	2 ug	16	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-136	Homo sapiens	blood serum	not applicable	not applicable	not applicable	33Y-78Y	female	not applicable	high-grade serous ovarian cancer	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 136	proteomic profiling by mass spectrometry	210329_OC_SC15_2ug_iRT3ul.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/210329_OC_SC15_2ug_iRT3ul.raw	2 ug	17	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-137	Homo sapiens	blood serum	not applicable	not applicable	not applicable	33Y-78Y	female	not applicable	high-grade serous ovarian cancer	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 137	proteomic profiling by mass spectrometry	210329_OC_SC16_2ug_iRT3ul.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/210329_OC_SC16_2ug_iRT3ul.raw	2 ug	18	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-138	Homo sapiens	blood serum	not applicable	not applicable	not applicable	33Y-78Y	female	not applicable	high-grade serous ovarian cancer	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 138	proteomic profiling by mass spectrometry	210329_OC_SC17_2ug_iRT3ul.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/210329_OC_SC17_2ug_iRT3ul.raw	2 ug	19	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-139	Homo sapiens	blood serum	not applicable	not applicable	not applicable	33Y-78Y	female	not applicable	high-grade serous ovarian cancer	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 139	proteomic profiling by mass spectrometry	210329_OC_SC22_2ug_iRT3ul.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/210329_OC_SC22_2ug_iRT3ul.raw	2 ug	20	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-140	Homo sapiens	blood serum	not applicable	not applicable	not applicable	33Y-78Y	female	not applicable	high-grade serous ovarian cancer	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 140	proteomic profiling by mass spectrometry	210329_OC_SC24_2ug_iRT3ul.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/210329_OC_SC24_2ug_iRT3ul.raw	2 ug	21	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-141	Homo sapiens	blood serum	not applicable	not applicable	not applicable	33Y-78Y	female	not applicable	high-grade serous ovarian cancer	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 141	proteomic profiling by mass spectrometry	210329_OC_SC27_2ug_iRT3ul.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/210329_OC_SC27_2ug_iRT3ul.raw	2 ug	22	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-142	Homo sapiens	blood serum	not applicable	not applicable	not applicable	33Y-78Y	female	not applicable	high-grade serous ovarian cancer	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 142	proteomic profiling by mass spectrometry	210329_OC_SC28_2ug_iRT3ul.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/210329_OC_SC28_2ug_iRT3ul.raw	2 ug	23	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-143	Homo sapiens	blood serum	not applicable	not applicable	not applicable	33Y-78Y	female	not applicable	high-grade serous ovarian cancer	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 143	proteomic profiling by mass spectrometry	210329_OC_SC30_2ug_iRT3ul.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/210329_OC_SC30_2ug_iRT3ul.raw	2 ug	24	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-144	Homo sapiens	blood serum	not applicable	not applicable	not applicable	33Y-78Y	female	not applicable	high-grade serous ovarian cancer	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 144	proteomic profiling by mass spectrometry	210329_OC_SC33_2ug_iRT3ul.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/210329_OC_SC33_2ug_iRT3ul.raw	2 ug	25	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-145	Homo sapiens	blood serum	not applicable	not applicable	not applicable	33Y-78Y	female	not applicable	high-grade serous ovarian cancer	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 145	proteomic profiling by mass spectrometry	210329_OC_SC34_2ug_iRT3ul.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/210329_OC_SC34_2ug_iRT3ul.raw	2 ug	26	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-146	Homo sapiens	blood serum	not applicable	not applicable	not applicable	33Y-78Y	female	not applicable	high-grade serous ovarian cancer	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 146	proteomic profiling by mass spectrometry	HighGrade_25ug_FAIMS_180min_FN01_C1_070321.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/HighGrade_25ug_FAIMS_180min_FN01_C1_070321.raw	25 ug	1	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-147	Homo sapiens	blood serum	not applicable	not applicable	not applicable	33Y-78Y	female	not applicable	high-grade serous ovarian cancer	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 147	proteomic profiling by mass spectrometry	HighGrade_25ug_FAIMS_180min_FN02_C2_070321.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/HighGrade_25ug_FAIMS_180min_FN02_C2_070321.raw	25 ug	2	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-148	Homo sapiens	blood serum	not applicable	not applicable	not applicable	33Y-78Y	female	not applicable	high-grade serous ovarian cancer	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 148	proteomic profiling by mass spectrometry	HighGrade_25ug_FAIMS_180min_FN03_C1_070321.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/HighGrade_25ug_FAIMS_180min_FN03_C1_070321.raw	25 ug	3	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-149	Homo sapiens	blood serum	not applicable	not applicable	not applicable	33Y-78Y	female	not applicable	high-grade serous ovarian cancer	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 149	proteomic profiling by mass spectrometry	HighGrade_25ug_FAIMS_180min_FN04_C2_070321.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/HighGrade_25ug_FAIMS_180min_FN04_C2_070321.raw	25 ug	4	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-150	Homo sapiens	blood serum	not applicable	not applicable	not applicable	33Y-78Y	female	not applicable	high-grade serous ovarian cancer	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 150	proteomic profiling by mass spectrometry	HighGrade_25ug_FAIMS_180min_FN05_C1_070321.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/HighGrade_25ug_FAIMS_180min_FN05_C1_070321.raw	25 ug	5	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-151	Homo sapiens	blood serum	not applicable	not applicable	not applicable	33Y-78Y	female	not applicable	high-grade serous ovarian cancer	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 151	proteomic profiling by mass spectrometry	HighGrade_25ug_FAIMS_180min_FN06_C2_070321.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/HighGrade_25ug_FAIMS_180min_FN06_C2_070321.raw	25 ug	6	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-152	Homo sapiens	blood serum	not applicable	not applicable	not applicable	33Y-78Y	female	not applicable	high-grade serous ovarian cancer	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 152	proteomic profiling by mass spectrometry	HighGrade_25ug_FAIMS_180min_FN07_C1_070321.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/HighGrade_25ug_FAIMS_180min_FN07_C1_070321.raw	25 ug	7	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-153	Homo sapiens	blood serum	not applicable	not applicable	not applicable	33Y-78Y	female	not applicable	high-grade serous ovarian cancer	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 153	proteomic profiling by mass spectrometry	HighGrade_25ug_FAIMS_180min_FN08_C2_070321.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/HighGrade_25ug_FAIMS_180min_FN08_C2_070321.raw	25 ug	8	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-154	Homo sapiens	blood serum	not applicable	not applicable	not applicable	33Y-78Y	female	not applicable	high-grade serous ovarian cancer	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 154	proteomic profiling by mass spectrometry	HighGrade_25ug_FAIMS_180min_FN09_C1_070321.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/HighGrade_25ug_FAIMS_180min_FN09_C1_070321.raw	25 ug	9	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-155	Homo sapiens	blood serum	not applicable	not applicable	not applicable	33Y-78Y	female	not applicable	high-grade serous ovarian cancer	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 155	proteomic profiling by mass spectrometry	HighGrade_25ug_FAIMS_180min_FN10_C2_070321.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/HighGrade_25ug_FAIMS_180min_FN10_C2_070321.raw	25 ug	10	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-156	Homo sapiens	blood serum	not applicable	not applicable	not applicable	33Y-78Y	female	not applicable	high-grade serous ovarian cancer	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 156	proteomic profiling by mass spectrometry	HighGrade_25ug_FAIMS_180min_FN11_C1_070321.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/HighGrade_25ug_FAIMS_180min_FN11_C1_070321.raw	25 ug	11	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-157	Homo sapiens	blood serum	not applicable	not applicable	not applicable	33Y-78Y	female	not applicable	high-grade serous ovarian cancer	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 157	proteomic profiling by mass spectrometry	HighGrade_25ug_FAIMS_180min_FN12_C2_070321.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/HighGrade_25ug_FAIMS_180min_FN12_C2_070321.raw	25 ug	12	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-158	Homo sapiens	blood serum	not applicable	not applicable	not applicable	33Y-78Y	female	not applicable	high-grade serous ovarian cancer	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 158	proteomic profiling by mass spectrometry	HighGrade_25ug_FAIMS_180min_FN13_C1_070321.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/HighGrade_25ug_FAIMS_180min_FN13_C1_070321.raw	25 ug	13	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-159	Homo sapiens	blood serum	not applicable	not applicable	not applicable	33Y-78Y	female	not applicable	high-grade serous ovarian cancer	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 159	proteomic profiling by mass spectrometry	HighGrade_25ug_FAIMS_180min_FN14_C2_070321.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/HighGrade_25ug_FAIMS_180min_FN14_C2_070321.raw	25 ug	14	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-160	Homo sapiens	blood serum	not applicable	not applicable	not applicable	33Y-78Y	female	not applicable	high-grade serous ovarian cancer	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 160	proteomic profiling by mass spectrometry	HighGrade_25ug_FAIMS_180min_FN15_C1_070321.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/HighGrade_25ug_FAIMS_180min_FN15_C1_070321.raw	25 ug	15	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-161	Homo sapiens	blood serum	not applicable	not applicable	not applicable	33Y-78Y	female	not applicable	high-grade serous ovarian cancer	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 161	proteomic profiling by mass spectrometry	HighGrade_25ug_FAIMS_180min_FN16_C2_070321.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/HighGrade_25ug_FAIMS_180min_FN16_C2_070321.raw	25 ug	16	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-162	Homo sapiens	blood serum	not applicable	not applicable	not applicable	33Y-78Y	female	not applicable	high-grade serous ovarian cancer	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 162	proteomic profiling by mass spectrometry	HighGrade_25ug_FAIMS_180min_FN17_C1_070321.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/HighGrade_25ug_FAIMS_180min_FN17_C1_070321.raw	25 ug	17	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-163	Homo sapiens	blood serum	not applicable	not applicable	not applicable	33Y-78Y	female	not applicable	high-grade serous ovarian cancer	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 163	proteomic profiling by mass spectrometry	HighGrade_25ug_FAIMS_180min_FN18_C2_070321.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/HighGrade_25ug_FAIMS_180min_FN18_C2_070321.raw	25 ug	18	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-164	Homo sapiens	blood serum	not applicable	not applicable	not applicable	33Y-78Y	female	not applicable	high-grade serous ovarian cancer	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 164	proteomic profiling by mass spectrometry	HighGrade_25ug_FAIMS_180min_FN19_C1_070321.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/HighGrade_25ug_FAIMS_180min_FN19_C1_070321.raw	25 ug	19	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-165	Homo sapiens	blood serum	not applicable	not applicable	not applicable	33Y-78Y	female	not applicable	high-grade serous ovarian cancer	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 165	proteomic profiling by mass spectrometry	HighGrade_25ug_FAIMS_180min_FN20_C2_070321.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/HighGrade_25ug_FAIMS_180min_FN20_C2_070321.raw	25 ug	20	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-166	Homo sapiens	blood serum	not applicable	not applicable	not applicable	33Y-78Y	female	not applicable	high-grade serous ovarian cancer	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 166	proteomic profiling by mass spectrometry	HighGrade_25ug_FAIMS_180min_FN21_C1_070321.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/HighGrade_25ug_FAIMS_180min_FN21_C1_070321.raw	25 ug	21	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-167	Homo sapiens	blood serum	not applicable	not applicable	not applicable	33Y-78Y	female	not applicable	high-grade serous ovarian cancer	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 167	proteomic profiling by mass spectrometry	HighGrade_25ug_FAIMS_180min_FN22_C2_070321.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/HighGrade_25ug_FAIMS_180min_FN22_C2_070321.raw	25 ug	22	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-168	Homo sapiens	blood serum	not applicable	not applicable	not applicable	33Y-78Y	female	not applicable	high-grade serous ovarian cancer	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 168	proteomic profiling by mass spectrometry	HighGrade_25ug_FAIMS_180min_FN23_C1_070321.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/HighGrade_25ug_FAIMS_180min_FN23_C1_070321.raw	25 ug	23	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-169	Homo sapiens	blood serum	not applicable	not applicable	not applicable	33Y-78Y	female	not applicable	high-grade serous ovarian cancer	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 169	proteomic profiling by mass spectrometry	HighGrade_25ug_FAIMS_180min_FN24_C2_070321.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/HighGrade_25ug_FAIMS_180min_FN24_C2_070321.raw	25 ug	24	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-170	Homo sapiens	blood serum	not applicable	not applicable	not applicable	27Y-77Y	female	not applicable	mucinous (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 170	proteomic profiling by mass spectrometry	Mucinous_25ug_FAIMS_180min_FN01_C1_061421.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Mucinous_25ug_FAIMS_180min_FN01_C1_061421.raw	25 ug	1	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-171	Homo sapiens	blood serum	not applicable	not applicable	not applicable	27Y-77Y	female	not applicable	mucinous (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 171	proteomic profiling by mass spectrometry	Mucinous_25ug_FAIMS_180min_FN02_C2_061421.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Mucinous_25ug_FAIMS_180min_FN02_C2_061421.raw	25 ug	2	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-172	Homo sapiens	blood serum	not applicable	not applicable	not applicable	27Y-77Y	female	not applicable	mucinous (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 172	proteomic profiling by mass spectrometry	Mucinous_25ug_FAIMS_180min_FN03_C1_061421.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Mucinous_25ug_FAIMS_180min_FN03_C1_061421.raw	25 ug	3	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-173	Homo sapiens	blood serum	not applicable	not applicable	not applicable	27Y-77Y	female	not applicable	mucinous (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 173	proteomic profiling by mass spectrometry	Mucinous_25ug_FAIMS_180min_FN04_C2_061421.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Mucinous_25ug_FAIMS_180min_FN04_C2_061421.raw	25 ug	4	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-174	Homo sapiens	blood serum	not applicable	not applicable	not applicable	27Y-77Y	female	not applicable	mucinous (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 174	proteomic profiling by mass spectrometry	Mucinous_25ug_FAIMS_180min_FN05_C1_061421.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Mucinous_25ug_FAIMS_180min_FN05_C1_061421.raw	25 ug	5	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-175	Homo sapiens	blood serum	not applicable	not applicable	not applicable	27Y-77Y	female	not applicable	mucinous (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 175	proteomic profiling by mass spectrometry	Mucinous_25ug_FAIMS_180min_FN06_C2_061421.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Mucinous_25ug_FAIMS_180min_FN06_C2_061421.raw	25 ug	6	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-176	Homo sapiens	blood serum	not applicable	not applicable	not applicable	27Y-77Y	female	not applicable	mucinous (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 176	proteomic profiling by mass spectrometry	Mucinous_25ug_FAIMS_180min_FN07_C1_061421.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Mucinous_25ug_FAIMS_180min_FN07_C1_061421.raw	25 ug	7	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-177	Homo sapiens	blood serum	not applicable	not applicable	not applicable	27Y-77Y	female	not applicable	mucinous (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 177	proteomic profiling by mass spectrometry	Mucinous_25ug_FAIMS_180min_FN08_C2_061421.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Mucinous_25ug_FAIMS_180min_FN08_C2_061421.raw	25 ug	8	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-178	Homo sapiens	blood serum	not applicable	not applicable	not applicable	27Y-77Y	female	not applicable	mucinous (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 178	proteomic profiling by mass spectrometry	Mucinous_25ug_FAIMS_180min_FN09_C1_061421.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Mucinous_25ug_FAIMS_180min_FN09_C1_061421.raw	25 ug	9	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-179	Homo sapiens	blood serum	not applicable	not applicable	not applicable	27Y-77Y	female	not applicable	mucinous (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 179	proteomic profiling by mass spectrometry	Mucinous_25ug_FAIMS_180min_FN10_C2_061421.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Mucinous_25ug_FAIMS_180min_FN10_C2_061421.raw	25 ug	10	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-180	Homo sapiens	blood serum	not applicable	not applicable	not applicable	27Y-77Y	female	not applicable	mucinous (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 180	proteomic profiling by mass spectrometry	Mucinous_25ug_FAIMS_180min_FN11_C1_061421.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Mucinous_25ug_FAIMS_180min_FN11_C1_061421.raw	25 ug	11	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-181	Homo sapiens	blood serum	not applicable	not applicable	not applicable	27Y-77Y	female	not applicable	mucinous (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 181	proteomic profiling by mass spectrometry	Mucinous_25ug_FAIMS_180min_FN12_C2_061421.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Mucinous_25ug_FAIMS_180min_FN12_C2_061421.raw	25 ug	12	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-182	Homo sapiens	blood serum	not applicable	not applicable	not applicable	27Y-77Y	female	not applicable	mucinous (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 182	proteomic profiling by mass spectrometry	Mucinous_25ug_FAIMS_180min_FN13_C1_061421.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Mucinous_25ug_FAIMS_180min_FN13_C1_061421.raw	25 ug	13	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-183	Homo sapiens	blood serum	not applicable	not applicable	not applicable	27Y-77Y	female	not applicable	mucinous (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 183	proteomic profiling by mass spectrometry	Mucinous_25ug_FAIMS_180min_FN14_C2_061421.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Mucinous_25ug_FAIMS_180min_FN14_C2_061421.raw	25 ug	14	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-184	Homo sapiens	blood serum	not applicable	not applicable	not applicable	27Y-77Y	female	not applicable	mucinous (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 184	proteomic profiling by mass spectrometry	Mucinous_25ug_FAIMS_180min_FN15_C1_061421.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Mucinous_25ug_FAIMS_180min_FN15_C1_061421.raw	25 ug	15	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-185	Homo sapiens	blood serum	not applicable	not applicable	not applicable	27Y-77Y	female	not applicable	mucinous (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 185	proteomic profiling by mass spectrometry	Mucinous_25ug_FAIMS_180min_FN16_C2_061421.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Mucinous_25ug_FAIMS_180min_FN16_C2_061421.raw	25 ug	16	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-186	Homo sapiens	blood serum	not applicable	not applicable	not applicable	27Y-77Y	female	not applicable	mucinous (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 186	proteomic profiling by mass spectrometry	Mucinous_25ug_FAIMS_180min_FN17_C1_061421.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Mucinous_25ug_FAIMS_180min_FN17_C1_061421.raw	25 ug	17	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-187	Homo sapiens	blood serum	not applicable	not applicable	not applicable	27Y-77Y	female	not applicable	mucinous (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 187	proteomic profiling by mass spectrometry	Mucinous_25ug_FAIMS_180min_FN18_C2_061421.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Mucinous_25ug_FAIMS_180min_FN18_C2_061421.raw	25 ug	18	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-188	Homo sapiens	blood serum	not applicable	not applicable	not applicable	27Y-77Y	female	not applicable	mucinous (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 188	proteomic profiling by mass spectrometry	Mucinous_25ug_FAIMS_180min_FN19_C1_061421.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Mucinous_25ug_FAIMS_180min_FN19_C1_061421.raw	25 ug	19	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-189	Homo sapiens	blood serum	not applicable	not applicable	not applicable	27Y-77Y	female	not applicable	mucinous (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 189	proteomic profiling by mass spectrometry	Mucinous_25ug_FAIMS_180min_FN20_C2_061421.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Mucinous_25ug_FAIMS_180min_FN20_C2_061421.raw	25 ug	20	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-190	Homo sapiens	blood serum	not applicable	not applicable	not applicable	27Y-77Y	female	not applicable	mucinous (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 190	proteomic profiling by mass spectrometry	Mucinous_25ug_FAIMS_180min_FN21_C1_061421.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Mucinous_25ug_FAIMS_180min_FN21_C1_061421.raw	25 ug	21	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-191	Homo sapiens	blood serum	not applicable	not applicable	not applicable	27Y-77Y	female	not applicable	mucinous (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 191	proteomic profiling by mass spectrometry	Mucinous_25ug_FAIMS_180min_FN22_C2_061421.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Mucinous_25ug_FAIMS_180min_FN22_C2_061421.raw	25 ug	22	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-192	Homo sapiens	blood serum	not applicable	not applicable	not applicable	27Y-77Y	female	not applicable	mucinous (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 192	proteomic profiling by mass spectrometry	Mucinous_25ug_FAIMS_180min_FN23_C1_061421.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Mucinous_25ug_FAIMS_180min_FN23_C1_061421.raw	25 ug	23	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-193	Homo sapiens	blood serum	not applicable	not applicable	not applicable	27Y-77Y	female	not applicable	mucinous (high-grade serous ovarian cancer)	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 193	proteomic profiling by mass spectrometry	Mucinous_25ug_FAIMS_180min_FN24_C2_061421.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/Mucinous_25ug_FAIMS_180min_FN24_C2_061421.raw	25 ug	24	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-194	Homo sapiens	blood serum	not applicable	not applicable	not applicable	25Y-70Y	female	not applicable	normal	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 194	proteomic profiling by mass spectrometry	210329_HC_M195_2ug_iRT3ul.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/210329_HC_M195_2ug_iRT3ul.raw	2 ug	1	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-195	Homo sapiens	blood serum	not applicable	not applicable	not applicable	25Y-70Y	female	not applicable	normal	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 195	proteomic profiling by mass spectrometry	210329_HC_M197_2ug_iRT3ul.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/210329_HC_M197_2ug_iRT3ul.raw	2 ug	2	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-196	Homo sapiens	blood serum	not applicable	not applicable	not applicable	25Y-70Y	female	not applicable	normal	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 196	proteomic profiling by mass spectrometry	210329_HC_M198_2ug_iRT3ul.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/210329_HC_M198_2ug_iRT3ul.raw	2 ug	3	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-197	Homo sapiens	blood serum	not applicable	not applicable	not applicable	25Y-70Y	female	not applicable	normal	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 197	proteomic profiling by mass spectrometry	210329_HC_M203_2ug_iRT3ul.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/210329_HC_M203_2ug_iRT3ul.raw	2 ug	4	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-198	Homo sapiens	blood serum	not applicable	not applicable	not applicable	25Y-70Y	female	not applicable	normal	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 198	proteomic profiling by mass spectrometry	210329_HC_M207_2ug_iRT3ul.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/210329_HC_M207_2ug_iRT3ul.raw	2 ug	5	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-199	Homo sapiens	blood serum	not applicable	not applicable	not applicable	25Y-70Y	female	not applicable	normal	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 199	proteomic profiling by mass spectrometry	210329_HC_M208_2ug_iRT3ul.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/210329_HC_M208_2ug_iRT3ul.raw	2 ug	6	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-200	Homo sapiens	blood serum	not applicable	not applicable	not applicable	25Y-70Y	female	not applicable	normal	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 200	proteomic profiling by mass spectrometry	210329_HC_M214_2ug_iRT3ul.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/210329_HC_M214_2ug_iRT3ul.raw	2 ug	7	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-201	Homo sapiens	blood serum	not applicable	not applicable	not applicable	25Y-70Y	female	not applicable	normal	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 201	proteomic profiling by mass spectrometry	210329_HC_M215_2ug_iRT3ul.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/210329_HC_M215_2ug_iRT3ul.raw	2 ug	8	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-202	Homo sapiens	blood serum	not applicable	not applicable	not applicable	25Y-70Y	female	not applicable	normal	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 202	proteomic profiling by mass spectrometry	210329_HC_M216_2ug_iRT3ul.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/210329_HC_M216_2ug_iRT3ul.raw	2 ug	9	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-203	Homo sapiens	blood serum	not applicable	not applicable	not applicable	25Y-70Y	female	not applicable	normal	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 203	proteomic profiling by mass spectrometry	210329_HC_M225_2ug_iRT3ul.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/210329_HC_M225_2ug_iRT3ul.raw	2 ug	10	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-204	Homo sapiens	blood serum	not applicable	not applicable	not applicable	25Y-70Y	female	not applicable	normal	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 204	proteomic profiling by mass spectrometry	210329_HC_M228_2ug_iRT3ul.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/210329_HC_M228_2ug_iRT3ul.raw	2 ug	11	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-205	Homo sapiens	blood serum	not applicable	not applicable	not applicable	25Y-70Y	female	not applicable	normal	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 205	proteomic profiling by mass spectrometry	210329_HC_M230_2ug_iRT3ul.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/210329_HC_M230_2ug_iRT3ul.raw	2 ug	12	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-206	Homo sapiens	blood serum	not applicable	not applicable	not applicable	25Y-70Y	female	not applicable	normal	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 206	proteomic profiling by mass spectrometry	210329_HC_M232_2ug_iRT3ul.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/210329_HC_M232_2ug_iRT3ul.raw	2 ug	13	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-207	Homo sapiens	blood serum	not applicable	not applicable	not applicable	25Y-70Y	female	not applicable	normal	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 207	proteomic profiling by mass spectrometry	210329_HC_M234_2ug_iRT3ul.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/210329_HC_M234_2ug_iRT3ul.raw	2 ug	14	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-208	Homo sapiens	blood serum	not applicable	not applicable	not applicable	25Y-70Y	female	not applicable	normal	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 208	proteomic profiling by mass spectrometry	210329_HC_M241_2ug_iRT3ul.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/210329_HC_M241_2ug_iRT3ul.raw	2 ug	15	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-209	Homo sapiens	blood serum	not applicable	not applicable	not applicable	25Y-70Y	female	not applicable	normal	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 209	proteomic profiling by mass spectrometry	210329_HC_M243_2ug_iRT3ul.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/210329_HC_M243_2ug_iRT3ul.raw	2 ug	16	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-210	Homo sapiens	blood serum	not applicable	not applicable	not applicable	25Y-70Y	female	not applicable	normal	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 210	proteomic profiling by mass spectrometry	210329_HC_M251_2ug_iRT3ul.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/210329_HC_M251_2ug_iRT3ul.raw	2 ug	17	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-211	Homo sapiens	blood serum	not applicable	not applicable	not applicable	25Y-70Y	female	not applicable	normal	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 211	proteomic profiling by mass spectrometry	210329_HC_M260_2ug_iRT3ul.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/210329_HC_M260_2ug_iRT3ul.raw	2 ug	18	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-212	Homo sapiens	blood serum	not applicable	not applicable	not applicable	25Y-70Y	female	not applicable	normal	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 212	proteomic profiling by mass spectrometry	210329_HC_M266_2ug_iRT3ul.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/210329_HC_M266_2ug_iRT3ul.raw	2 ug	19	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-213	Homo sapiens	blood serum	not applicable	not applicable	not applicable	25Y-70Y	female	not applicable	normal	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 213	proteomic profiling by mass spectrometry	210329_HC_M267_2ug_iRT3ul.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/210329_HC_M267_2ug_iRT3ul.raw	2 ug	20	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-214	Homo sapiens	blood serum	not applicable	not applicable	not applicable	25Y-70Y	female	not applicable	normal	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 214	proteomic profiling by mass spectrometry	210329_HC_M273_2ug_iRT3ul.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/210329_HC_M273_2ug_iRT3ul.raw	2 ug	21	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-215	Homo sapiens	blood serum	not applicable	not applicable	not applicable	25Y-70Y	female	not applicable	normal	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 215	proteomic profiling by mass spectrometry	210329_HC_M274_2ug_iRT3ul.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/210329_HC_M274_2ug_iRT3ul.raw	2 ug	22	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-216	Homo sapiens	blood serum	not applicable	not applicable	not applicable	25Y-70Y	female	not applicable	normal	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 216	proteomic profiling by mass spectrometry	210329_HC_M275_2ug_iRT3ul.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/210329_HC_M275_2ug_iRT3ul.raw	2 ug	23	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-217	Homo sapiens	blood serum	not applicable	not applicable	not applicable	25Y-70Y	female	not applicable	normal	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 217	proteomic profiling by mass spectrometry	210329_HC_M276_2ug_iRT3ul.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/210329_HC_M276_2ug_iRT3ul.raw	2 ug	24	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-218	Homo sapiens	blood serum	not applicable	not applicable	not applicable	25Y-70Y	female	not applicable	normal	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 218	proteomic profiling by mass spectrometry	HealthyCtrl_25ug_FAIMS_120min_FN05_C1_060721.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/HealthyCtrl_25ug_FAIMS_120min_FN05_C1_060721.raw	25 ug	1	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-219	Homo sapiens	blood serum	not applicable	not applicable	not applicable	25Y-70Y	female	not applicable	normal	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 219	proteomic profiling by mass spectrometry	HealthyCtrl_25ug_FAIMS_120min_FN06_C2_060721.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/HealthyCtrl_25ug_FAIMS_120min_FN06_C2_060721.raw	25 ug	2	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-220	Homo sapiens	blood serum	not applicable	not applicable	not applicable	25Y-70Y	female	not applicable	normal	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 220	proteomic profiling by mass spectrometry	HealthyCtrl_25ug_FAIMS_120min_FN07_C1_060721.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/HealthyCtrl_25ug_FAIMS_120min_FN07_C1_060721.raw	25 ug	3	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-221	Homo sapiens	blood serum	not applicable	not applicable	not applicable	25Y-70Y	female	not applicable	normal	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 221	proteomic profiling by mass spectrometry	HealthyCtrl_25ug_FAIMS_120min_FN08_C2_060721.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/HealthyCtrl_25ug_FAIMS_120min_FN08_C2_060721.raw	25 ug	4	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-222	Homo sapiens	blood serum	not applicable	not applicable	not applicable	25Y-70Y	female	not applicable	normal	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 222	proteomic profiling by mass spectrometry	HealthyCtrl_25ug_FAIMS_120min_FN09_C1_060721.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/HealthyCtrl_25ug_FAIMS_120min_FN09_C1_060721.raw	25 ug	5	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-223	Homo sapiens	blood serum	not applicable	not applicable	not applicable	25Y-70Y	female	not applicable	normal	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 223	proteomic profiling by mass spectrometry	HealthyCtrl_25ug_FAIMS_120min_FN10_C2_060721.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/HealthyCtrl_25ug_FAIMS_120min_FN10_C2_060721.raw	25 ug	6	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-224	Homo sapiens	blood serum	not applicable	not applicable	not applicable	25Y-70Y	female	not applicable	normal	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 224	proteomic profiling by mass spectrometry	HealthyCtrl_25ug_FAIMS_120min_FN11_C1_060721.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/HealthyCtrl_25ug_FAIMS_120min_FN11_C1_060721.raw	25 ug	7	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-225	Homo sapiens	blood serum	not applicable	not applicable	not applicable	25Y-70Y	female	not applicable	normal	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 225	proteomic profiling by mass spectrometry	HealthyCtrl_25ug_FAIMS_120min_FN12_C2_060721.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/HealthyCtrl_25ug_FAIMS_120min_FN12_C2_060721.raw	25 ug	8	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-226	Homo sapiens	blood serum	not applicable	not applicable	not applicable	25Y-70Y	female	not applicable	normal	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 226	proteomic profiling by mass spectrometry	HealthyCtrl_25ug_FAIMS_120min_FN13_C1_060721.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/HealthyCtrl_25ug_FAIMS_120min_FN13_C1_060721.raw	25 ug	9	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-227	Homo sapiens	blood serum	not applicable	not applicable	not applicable	25Y-70Y	female	not applicable	normal	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 227	proteomic profiling by mass spectrometry	HealthyCtrl_25ug_FAIMS_120min_FN14_C2_060721.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/HealthyCtrl_25ug_FAIMS_120min_FN14_C2_060721.raw	25 ug	10	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-228	Homo sapiens	blood serum	not applicable	not applicable	not applicable	25Y-70Y	female	not applicable	normal	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 228	proteomic profiling by mass spectrometry	HealthyCtrl_25ug_FAIMS_120min_FN15_C1_060721.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/HealthyCtrl_25ug_FAIMS_120min_FN15_C1_060721.raw	25 ug	11	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-229	Homo sapiens	blood serum	not applicable	not applicable	not applicable	25Y-70Y	female	not applicable	normal	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 229	proteomic profiling by mass spectrometry	HealthyCtrl_25ug_FAIMS_120min_FN16_C2_060721.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/HealthyCtrl_25ug_FAIMS_120min_FN16_C2_060721.raw	25 ug	12	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-230	Homo sapiens	blood serum	not applicable	not applicable	not applicable	25Y-70Y	female	not applicable	normal	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 230	proteomic profiling by mass spectrometry	HealthyCtrl_25ug_FAIMS_120min_FN17_C1_060721.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/HealthyCtrl_25ug_FAIMS_120min_FN17_C1_060721.raw	25 ug	13	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-231	Homo sapiens	blood serum	not applicable	not applicable	not applicable	25Y-70Y	female	not applicable	normal	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 231	proteomic profiling by mass spectrometry	HealthyCtrl_25ug_FAIMS_120min_FN18_C2_060721.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/HealthyCtrl_25ug_FAIMS_120min_FN18_C2_060721.raw	25 ug	14	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-232	Homo sapiens	blood serum	not applicable	not applicable	not applicable	25Y-70Y	female	not applicable	normal	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 232	proteomic profiling by mass spectrometry	HealthyCtrl_25ug_FAIMS_120min_FN19_C1_060721.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/HealthyCtrl_25ug_FAIMS_120min_FN19_C1_060721.raw	25 ug	15	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-233	Homo sapiens	blood serum	not applicable	not applicable	not applicable	25Y-70Y	female	not applicable	normal	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 233	proteomic profiling by mass spectrometry	HealthyCtrl_25ug_FAIMS_120min_FN20_C2_060721.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/HealthyCtrl_25ug_FAIMS_120min_FN20_C2_060721.raw	25 ug	16	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-234	Homo sapiens	blood serum	not applicable	not applicable	not applicable	25Y-70Y	female	not applicable	normal	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 234	proteomic profiling by mass spectrometry	HealthyCtrl_25ug_FAIMS_120min_FN21_C1_060721.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/HealthyCtrl_25ug_FAIMS_120min_FN21_C1_060721.raw	25 ug	17	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-235	Homo sapiens	blood serum	not applicable	not applicable	not applicable	25Y-70Y	female	not applicable	normal	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 235	proteomic profiling by mass spectrometry	HealthyCtrl_25ug_FAIMS_120min_FN22_C2_060721.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/HealthyCtrl_25ug_FAIMS_120min_FN22_C2_060721.raw	25 ug	18	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-236	Homo sapiens	blood serum	not applicable	not applicable	not applicable	25Y-70Y	female	not applicable	normal	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 236	proteomic profiling by mass spectrometry	HealthyCtrl_25ug_FAIMS_120min_FN23_C1_060721.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/HealthyCtrl_25ug_FAIMS_120min_FN23_C1_060721.raw	25 ug	19	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-237	Homo sapiens	blood serum	not applicable	not applicable	not applicable	25Y-70Y	female	not applicable	normal	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 237	proteomic profiling by mass spectrometry	HealthyCtrl_25ug_FAIMS_120min_FN24_C2_060721.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/HealthyCtrl_25ug_FAIMS_120min_FN24_C2_060721.raw	25 ug	20	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-238	Homo sapiens	blood serum	not applicable	not applicable	not applicable	25Y-70Y	female	not applicable	normal	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 238	proteomic profiling by mass spectrometry	HealthyCtrl_25ug_FAIMS_180min_FN01_C1_060721.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/HealthyCtrl_25ug_FAIMS_180min_FN01_C1_060721.raw	25 ug	21	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-239	Homo sapiens	blood serum	not applicable	not applicable	not applicable	25Y-70Y	female	not applicable	normal	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 239	proteomic profiling by mass spectrometry	HealthyCtrl_25ug_FAIMS_180min_FN02_C2_060721.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/HealthyCtrl_25ug_FAIMS_180min_FN02_C2_060721.raw	25 ug	22	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-240	Homo sapiens	blood serum	not applicable	not applicable	not applicable	25Y-70Y	female	not applicable	normal	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 240	proteomic profiling by mass spectrometry	HealthyCtrl_25ug_FAIMS_180min_FN03_C1_060721.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/HealthyCtrl_25ug_FAIMS_180min_FN03_C1_060721.raw	25 ug	23	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-241	Homo sapiens	blood serum	not applicable	not applicable	not applicable	25Y-70Y	female	not applicable	normal	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 241	proteomic profiling by mass spectrometry	HealthyCtrl_25ug_FAIMS_180min_FN04_C2_060721.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/HealthyCtrl_25ug_FAIMS_180min_FN04_C2_060721.raw	25 ug	24	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-242	Homo sapiens	blood serum	not applicable	not applicable	not applicable	25Y-70Y	female	not applicable	normal	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 242	proteomic profiling by mass spectrometry	HealthyCtrl_40ug_FAIMS_180min_FN01_C1_061021.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/HealthyCtrl_40ug_FAIMS_180min_FN01_C1_061021.raw	40 ug	1	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-243	Homo sapiens	blood serum	not applicable	not applicable	not applicable	25Y-70Y	female	not applicable	normal	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 243	proteomic profiling by mass spectrometry	HealthyCtrl_40ug_FAIMS_180min_FN02_C2_061021.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/HealthyCtrl_40ug_FAIMS_180min_FN02_C2_061021.raw	40 ug	2	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-244	Homo sapiens	blood serum	not applicable	not applicable	not applicable	25Y-70Y	female	not applicable	normal	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 244	proteomic profiling by mass spectrometry	HealthyCtrl_40ug_FAIMS_180min_FN03_C1_061021.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/HealthyCtrl_40ug_FAIMS_180min_FN03_C1_061021.raw	40 ug	3	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-245	Homo sapiens	blood serum	not applicable	not applicable	not applicable	25Y-70Y	female	not applicable	normal	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 245	proteomic profiling by mass spectrometry	HealthyCtrl_40ug_FAIMS_180min_FN04_C2_061021.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/HealthyCtrl_40ug_FAIMS_180min_FN04_C2_061021.raw	40 ug	4	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-246	Homo sapiens	blood serum	not applicable	not applicable	not applicable	25Y-70Y	female	not applicable	normal	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 246	proteomic profiling by mass spectrometry	HealthyCtrl_40ug_FAIMS_180min_FN05_C1_061021.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/HealthyCtrl_40ug_FAIMS_180min_FN05_C1_061021.raw	40 ug	5	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-247	Homo sapiens	blood serum	not applicable	not applicable	not applicable	25Y-70Y	female	not applicable	normal	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 247	proteomic profiling by mass spectrometry	HealthyCtrl_40ug_FAIMS_180min_FN06_C2_061021.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/HealthyCtrl_40ug_FAIMS_180min_FN06_C2_061021.raw	40 ug	6	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-248	Homo sapiens	blood serum	not applicable	not applicable	not applicable	25Y-70Y	female	not applicable	normal	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 248	proteomic profiling by mass spectrometry	HealthyCtrl_40ug_FAIMS_180min_FN07_C1_061021.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/HealthyCtrl_40ug_FAIMS_180min_FN07_C1_061021.raw	40 ug	7	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-249	Homo sapiens	blood serum	not applicable	not applicable	not applicable	25Y-70Y	female	not applicable	normal	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 249	proteomic profiling by mass spectrometry	HealthyCtrl_40ug_FAIMS_180min_FN08_C2_061021.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/HealthyCtrl_40ug_FAIMS_180min_FN08_C2_061021.raw	40 ug	8	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-250	Homo sapiens	blood serum	not applicable	not applicable	not applicable	25Y-70Y	female	not applicable	normal	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 250	proteomic profiling by mass spectrometry	HealthyCtrl_40ug_FAIMS_180min_FN09_C1_061021.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/HealthyCtrl_40ug_FAIMS_180min_FN09_C1_061021.raw	40 ug	9	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-251	Homo sapiens	blood serum	not applicable	not applicable	not applicable	25Y-70Y	female	not applicable	normal	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 251	proteomic profiling by mass spectrometry	HealthyCtrl_40ug_FAIMS_180min_FN10_C2_061021.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/HealthyCtrl_40ug_FAIMS_180min_FN10_C2_061021.raw	40 ug	10	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-252	Homo sapiens	blood serum	not applicable	not applicable	not applicable	25Y-70Y	female	not applicable	normal	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 252	proteomic profiling by mass spectrometry	HealthyCtrl_40ug_FAIMS_180min_FN11_C1_061021.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/HealthyCtrl_40ug_FAIMS_180min_FN11_C1_061021.raw	40 ug	11	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-253	Homo sapiens	blood serum	not applicable	not applicable	not applicable	25Y-70Y	female	not applicable	normal	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 253	proteomic profiling by mass spectrometry	HealthyCtrl_40ug_FAIMS_180min_FN12_C2_061021.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/HealthyCtrl_40ug_FAIMS_180min_FN12_C2_061021.raw	40 ug	12	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-254	Homo sapiens	blood serum	not applicable	not applicable	not applicable	25Y-70Y	female	not applicable	normal	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 254	proteomic profiling by mass spectrometry	HealthyCtrl_40ug_FAIMS_180min_FN13_C1_061021.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/HealthyCtrl_40ug_FAIMS_180min_FN13_C1_061021.raw	40 ug	13	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-255	Homo sapiens	blood serum	not applicable	not applicable	not applicable	25Y-70Y	female	not applicable	normal	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 255	proteomic profiling by mass spectrometry	HealthyCtrl_40ug_FAIMS_180min_FN14_C2_061021.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/HealthyCtrl_40ug_FAIMS_180min_FN14_C2_061021.raw	40 ug	14	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-256	Homo sapiens	blood serum	not applicable	not applicable	not applicable	25Y-70Y	female	not applicable	normal	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 256	proteomic profiling by mass spectrometry	HealthyCtrl_40ug_FAIMS_180min_FN15_C1_061021.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/HealthyCtrl_40ug_FAIMS_180min_FN15_C1_061021.raw	40 ug	15	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-257	Homo sapiens	blood serum	not applicable	not applicable	not applicable	25Y-70Y	female	not applicable	normal	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 257	proteomic profiling by mass spectrometry	HealthyCtrl_40ug_FAIMS_180min_FN16_C2_061021.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/HealthyCtrl_40ug_FAIMS_180min_FN16_C2_061021.raw	40 ug	16	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-258	Homo sapiens	blood serum	not applicable	not applicable	not applicable	25Y-70Y	female	not applicable	normal	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 258	proteomic profiling by mass spectrometry	HealthyCtrl_40ug_FAIMS_180min_FN17_C1_061021.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/HealthyCtrl_40ug_FAIMS_180min_FN17_C1_061021.raw	40 ug	17	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-259	Homo sapiens	blood serum	not applicable	not applicable	not applicable	25Y-70Y	female	not applicable	normal	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 259	proteomic profiling by mass spectrometry	HealthyCtrl_40ug_FAIMS_180min_FN18_C2_061021.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/HealthyCtrl_40ug_FAIMS_180min_FN18_C2_061021.raw	40 ug	18	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-260	Homo sapiens	blood serum	not applicable	not applicable	not applicable	25Y-70Y	female	not applicable	normal	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 260	proteomic profiling by mass spectrometry	HealthyCtrl_40ug_FAIMS_180min_FN19_C1_061021.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/HealthyCtrl_40ug_FAIMS_180min_FN19_C1_061021.raw	40 ug	19	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-261	Homo sapiens	blood serum	not applicable	not applicable	not applicable	25Y-70Y	female	not applicable	normal	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 261	proteomic profiling by mass spectrometry	HealthyCtrl_40ug_FAIMS_180min_FN20_C2_061021.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/HealthyCtrl_40ug_FAIMS_180min_FN20_C2_061021.raw	40 ug	20	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-262	Homo sapiens	blood serum	not applicable	not applicable	not applicable	25Y-70Y	female	not applicable	normal	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 262	proteomic profiling by mass spectrometry	HealthyCtrl_40ug_FAIMS_180min_FN21_C1_061021.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/HealthyCtrl_40ug_FAIMS_180min_FN21_C1_061021.raw	40 ug	21	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-263	Homo sapiens	blood serum	not applicable	not applicable	not applicable	25Y-70Y	female	not applicable	normal	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 263	proteomic profiling by mass spectrometry	HealthyCtrl_40ug_FAIMS_180min_FN22_C2_061021.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/HealthyCtrl_40ug_FAIMS_180min_FN22_C2_061021.raw	40 ug	22	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-264	Homo sapiens	blood serum	not applicable	not applicable	not applicable	25Y-70Y	female	not applicable	normal	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 264	proteomic profiling by mass spectrometry	HealthyCtrl_40ug_FAIMS_180min_FN23_C1_061021.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/HealthyCtrl_40ug_FAIMS_180min_FN23_C1_061021.raw	40 ug	23	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
PXD033169-Sample-265	Homo sapiens	blood serum	not applicable	not applicable	not applicable	25Y-70Y	female	not applicable	normal	depleted	Top 14 a multiple affinity removal column (MARS14)	1	run 265	proteomic profiling by mass spectrometry	HealthyCtrl_40ug_FAIMS_180min_FN24_C2_061021.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2022/08/PXD033169/HealthyCtrl_40ug_FAIMS_180min_FN24_C2_061021.raw	40 ug	24	AC=PRIDE:0000554;NT= Hydrophilic interaction chromatography (HILIC)	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1003028;NT=Orbitrap Exploris 480	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Deamidated;AC=UNIMOD:7;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm	0.01 Da	blood serum
